Huntleigh Advisors, Inc. Adaptive Biotechnologies Corp Transaction History
Huntleigh Advisors, Inc.
- $586 Billion
- Q3 2025
A detailed history of Huntleigh Advisors, Inc. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Huntleigh Advisors, Inc. holds 82,038 shares of ADPT stock, worth $1.16 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
82,038Holding current value
$1.16 Million% of portfolio
0.21%Shares
1 transactions
Others Institutions Holding ADPT
# of Institutions
290Shares Held
147MCall Options Held
23.5KPut Options Held
33.3K-
Viking Global Investors LP30MShares$423 Million1.27% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$164 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$159 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN5.97MShares$84.2 Million0.02% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.3.65MShares$51.5 Million0.03% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $2.01B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...